Company Filing History:
Years Active: 2007
Title: Tricia Ann Kwan: Innovating Anticancer Agents
Introduction
Tricia Ann Kwan is a distinguished inventor based in Groton, Connecticut. She has made significant contributions to the field of pharmaceutical chemistry, focusing on innovative compounds that serve as potential anticancer agents. With her expertise, she continues to pave the way for advancements in cancer treatment.
Latest Patents
Tricia Ann Kwan holds a patent for "Isothiazole derivatives useful as anticancer agents." This invention relates to specific compounds that can be utilized in the formulation of pharmaceutical compositions aimed at treating hyperproliferative disorders in mammals. The patent encompasses compounds of a defined formula, including their pharmaceutically acceptable salts, prodrugs, solvates, or hydrates.
Career Highlights
Kwan is associated with Pfizer Corporation, a leading pharmaceutical company where her research focuses on creating effective medications that address critical health challenges, particularly cancer. Her work ensures that scientific advancements translate into tangible therapeutic options for patients.
Collaborations
Throughout her career, Tricia has collaborated with notable colleagues such as Blaise S. Lippa and Joel Morris. These partnerships exemplify the importance of teamwork in research and development, leading to innovative breakthroughs in the pharmaceutical industry.
Conclusion
Tricia Ann Kwan's contributions to cancer research and her patent for isothiazole derivatives highlight her role as an influential inventor in the pharmaceutical field. Her ongoing efforts at Pfizer Corporation, coupled with collaborative initiatives, reinforce the significance of innovation in developing effective treatments for serious health conditions.